QUOTE AND NEWS
newratings.com  Sep 10  Comment 
BASEL (dpa-AFX) - Novartis International AG (NVS) reported new data that reinforces the clinical importance of measuring brain shrinkage (brain volume loss) in multiple sclerosis. An association between the rate of brain shrinkage and increased...
Benzinga  Sep 9  Comment 
Actavis plc (NYSE: ACT) today confirmed that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) has voted to recommend against approval of Actavis' New Drug Application (NDA) for the fixed-dose...
SeekingAlpha  Sep 8  Comment 
By Alpha Strategist: At a time when the entire pharmaceutical industry is struggling against the flourishing generic market, Novartis AG (NYSE:NVS) has plausibly come up with a breakthrough medicine bringing forth wonderful news for cardiac...
GenEng News  Sep 8  Comment 
Ophthotech achieved a $50 million enrollment milestone payment from Novartis Pharma as part of an ex-U.S. licensing and commercialization agreement focused on the treatment of wet age-related macular degeneration (AMD) in a Fovista® Phase III...
StreetInsider.com  Sep 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Merus+Labs+Int%27l+%28MSLI%29+Acquires+Certain+Sintrom+Rights+from+Novartis+%28NVS%29/9812639.html for the full story.
Motley Fool  Sep 7  Comment 
Let’s look at Novartis’ investments in the $49 billion mobile health market.
newratings.com  Sep 4  Comment 
BASEL (dpa-AFX) - Vectura Group Plc.(VEC.L) said Thursday that its alliance partner Novartis, has confirmed that Pfizer Limited has signed an exclusive agreement to commercialise Ultibro Breezhaler (indacaterol / glycopyrronium bromide) and Seebri...
newratings.com  Sep 3  Comment 
BRUSSELS (dpa-AFX) - Swiss stocks rallied to all-time highs on Wednesday, bolstered by hopes that its neighbors will be offered economic stimulus from the European Central Bank. The ECB is widely expected to announce quantitative easing tomorrow...
SeekingAlpha  Sep 3  Comment 
By Balanced Investing: Novartis AG (NVS) is involved in the research, development, marketing and manufacturing of pharmaceuticals and health care products. In the evolving pharmaceutical industry, Novartis is well positioned with its diversified...




 

Fuerralz? That's marvelously good to know.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki